Squarepoint’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Squarepoint’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,016	Closed	-$107K	–	4642
2023 Q3	$107K	Buy	+16,016	New	+$133K	﹤0.01%	3552
2022 Q2	–	Sell	-108,792	Closed	-$867K	–	3549
2022 Q1	$867K	Buy	+108,792	New	+$691K	﹤0.01%	1677

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Squarepoint's PNT Position: Q4 2023 in Review

Squarepoint sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 16,016 shares — an estimated $107K sold.

Squarepoint first reported a position in PNT in Q1 2022 and held it in 2 quarters. The position peaked at $867K in Q1 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Squarepoint reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Squarepoint sold 16,016 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $107K.
Squarepoint first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Squarepoint's POINT Biopharma Global Inc. Common Stock position peaked at $867K in Q1 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Squarepoint's 13F filing for Q4 2023, filed 14 Feb 2024.